A Method for Generating New Datasets Based on Copy Number for Cancer Analysis
New data sources for the analysis of cancer data are rapidly supplementing the large number of gene-expression markers used for current methods of analysis. Significant among these new sources are copy number variation (CNV) datasets, which typically enumerate several hundred thousand CNVs distribut...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2015/467514 |
id |
doaj-b4bdcbe7e670438bb42074e0d2cdab79 |
---|---|
record_format |
Article |
spelling |
doaj-b4bdcbe7e670438bb42074e0d2cdab792020-11-24T21:06:09ZengHindawi LimitedBioMed Research International2314-61332314-61412015-01-01201510.1155/2015/467514467514A Method for Generating New Datasets Based on Copy Number for Cancer AnalysisShinuk Kim0Mark Kon1Hyunsik Kang2College of Liberal Arts, Sangmyung University, Cheonan, Chungnam 330-720, Republic of Korea Department of Mathematics and Statistics, Boston University, Boston, MA 02215, USACollege of Sport Science, Sungkyunkwan University, Suwon 440-746, Republic of Korea New data sources for the analysis of cancer data are rapidly supplementing the large number of gene-expression markers used for current methods of analysis. Significant among these new sources are copy number variation (CNV) datasets, which typically enumerate several hundred thousand CNVs distributed throughout the genome. Several useful algorithms allow systems-level analyses of such datasets. However, these rich data sources have not yet been analyzed as deeply as gene-expression data. To address this issue, the extensive toolsets used for analyzing expression data in cancerous and noncancerous tissue (e.g., gene set enrichment analysis and phenotype prediction) could be redirected to extract a great deal of predictive information from CNV data, in particular those derived from cancers. Here we present a software package capable of preprocessing standard Agilent copy number datasets into a form to which essentially all expression analysis tools can be applied. We illustrate the use of this toolset in predicting the survival time of patients with ovarian cancer or glioblastoma multiforme and also provide an analysis of gene- and pathway-level deletions in these two types of cancer.http://dx.doi.org/10.1155/2015/467514 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shinuk Kim Mark Kon Hyunsik Kang |
spellingShingle |
Shinuk Kim Mark Kon Hyunsik Kang A Method for Generating New Datasets Based on Copy Number for Cancer Analysis BioMed Research International |
author_facet |
Shinuk Kim Mark Kon Hyunsik Kang |
author_sort |
Shinuk Kim |
title |
A Method for Generating New Datasets Based on Copy Number for Cancer Analysis |
title_short |
A Method for Generating New Datasets Based on Copy Number for Cancer Analysis |
title_full |
A Method for Generating New Datasets Based on Copy Number for Cancer Analysis |
title_fullStr |
A Method for Generating New Datasets Based on Copy Number for Cancer Analysis |
title_full_unstemmed |
A Method for Generating New Datasets Based on Copy Number for Cancer Analysis |
title_sort |
method for generating new datasets based on copy number for cancer analysis |
publisher |
Hindawi Limited |
series |
BioMed Research International |
issn |
2314-6133 2314-6141 |
publishDate |
2015-01-01 |
description |
New data sources for the analysis of cancer data are rapidly supplementing the large number of gene-expression markers used for current methods of analysis. Significant among these new sources are copy number variation (CNV) datasets, which typically enumerate several hundred thousand CNVs distributed throughout the genome. Several useful algorithms allow systems-level analyses of such datasets. However, these rich data sources have not yet been analyzed as deeply as gene-expression data. To address this issue, the extensive toolsets used for analyzing expression data in cancerous and noncancerous tissue (e.g., gene set enrichment analysis and phenotype prediction) could be redirected to extract a great deal of predictive information from CNV data, in particular those derived from cancers. Here we present a software package capable of preprocessing standard Agilent copy number datasets into a form to which essentially all expression analysis tools can be applied. We illustrate the use of this toolset in predicting the survival time of patients with ovarian cancer or glioblastoma multiforme and also provide an analysis of gene- and pathway-level deletions in these two types of cancer. |
url |
http://dx.doi.org/10.1155/2015/467514 |
work_keys_str_mv |
AT shinukkim amethodforgeneratingnewdatasetsbasedoncopynumberforcanceranalysis AT markkon amethodforgeneratingnewdatasetsbasedoncopynumberforcanceranalysis AT hyunsikkang amethodforgeneratingnewdatasetsbasedoncopynumberforcanceranalysis AT shinukkim methodforgeneratingnewdatasetsbasedoncopynumberforcanceranalysis AT markkon methodforgeneratingnewdatasetsbasedoncopynumberforcanceranalysis AT hyunsikkang methodforgeneratingnewdatasetsbasedoncopynumberforcanceranalysis |
_version_ |
1716766639345631232 |